An analysis of 15 LCNEC cases showed that it had an immunochemical expression of p53, point mutation of p53, c-RAF-1, and K-ras-2 indicating genetic similarity with SCLC (17). Here, KRAS is linked to large cell neuroendocrine carcinoma.